NASDAQ: AMGN - Amgen

Rentabilidad a seis meses: -3.84%
Rendimiento de dividendos: +2.92%
Sector: Healthcare

Noticias Telegrama
FTC sues to stop Amgen’s $27.8B deal for Horizon Therapeutics

18 noviembre 17:52 FTC sues to stop Amgen’s $27.8B deal for Horizon Therapeutics

Biden pushes Congress to allow Medicare to negotiate drug prices

18 noviembre 16:20 Biden pushes Congress to allow Medicare to negotiate drug prices